If you're searching for nootropics for studying and exams, you probably want one answer: do the trials show these things actually raise grades or test scores? Here's the honest version: the research in this space mostly doesn't test that question at all. Most nootropic trials measure narrower things—reaction time, working-memory accuracy, attention-switching speed, self-rated alertness—not GPA, exam pass rates, or final grades. The one combination with solid, independently published trial support (caffeine paired with L-theanine) improves short-term alertness and attention, not academic outcomes directly. Here's what the evidence record actually supports, what nonprescribed stimulant use adds in risk, and what that leaves you to decide.
What the trials actually measured—and what they didn't
A 2025 systematic review of nootropic use among university students, from the Universidad de la República in Montevideo, concluded that nootropic use functions more as a stress-coping behavior than as something with solid causal evidence tying it to improved academic performance—and noted directly that causal evidence on academic outcomes remains limited. A separate systematic review of “smart drug” use among university students, published through the University of Hertfordshire, found that students take these substances specifically in the belief they'll improve exam performance, without establishing that the belief is backed by outcome data.
That distinction matters for how you read any marketing claim. A supplement that improved attention-switching accuracy in a lab test is not the same as a supplement shown to improve your exam score. Only the first kind of claim currently has trial support.
The evidence record
Here's what's actually been tested, by intervention, so you can see where the data stops and the marketing starts:
- Caffeine + L-theanine (combined doses). Tested in healthy young adults at combinations from 40 mg caffeine with 97 mg L-theanine up to 150 mg caffeine with 250 mg L-theanine, against placebo. A 2014 meta-analysis pooling 11 placebo-controlled trials found moderate improvements in alertness and attention-switching accuracy in the first two hours after dosing. A 2025 double-blind crossover trial in 12 elite wrestlers found caffeine alone raised self-reported anxiety and a racing heart in 92% of participants, versus 17% on the caffeine-theanine combination. Funding: academic-affiliated research, not industry-sponsored. Matches the marketing? Supports “more alert, sharper attention” claims. Does not support “better grades” or “exam performance” claims some sellers attach to it.
- Multi-ingredient dietary nootropic blends (general category). One published randomized, triple-blind, placebo-controlled crossover trial tested a proprietary blend in 26 healthy young adults and found improvement on select same-day cognitive measures. No repeat-dose or academic-outcome data exists for this trial, and the funding source isn't confirmed from the material I could access—verify sponsor disclosures before citing this against any specific branded product, since one small trial on one blend doesn't establish that a different product with a different formula will replicate it.
- Branded “exam condition” ingredient studies (e.g., Memophenol). A crossover trial in 30 French graduate students, ages 18–25, reported a 36% increase in cognitive performance versus placebo under simulated exam conditions—but this result comes from the ingredient developer's own press release, not a peer-reviewed journal article I could locate independently. That's a meaningful conflict-of-interest flag: a company's study of its own ingredient, publicized by the company, is weaker evidence than an independently funded, peer-reviewed trial, even when the result looks impressive.
- Nonprescribed stimulant use (Adderall, Ritalin, modafinil taken without a prescription). Mostly studied through surveys and observational research rather than controlled academic-outcome trials. Students report using these substances because they believe it will help them study or test better, not because a trial demonstrated it reliably does. These are Schedule II controlled substances in the U.S. because of documented risks including misuse, addiction, overdose, and diversion, per the FDA. Using them without a prescription, or sharing someone else's prescription, carries legal as well as health risk—on top of the fact that no controlled trial we could verify shows a grade or exam-score benefit to justify that risk.
Where the research is strongest: caffeine and L-theanine
If you're looking for the best-supported option in this space, it isn't a branded formula—it's the caffeine-and-L-theanine combination, which has the most independently funded, peer-reviewed trial data behind it. That's a real, measurable short-term effect on alertness and attention-switching. It is not the same as a demonstrated grade improvement, and no trial we could find has tried to connect the two directly.
What nonprescribed stimulants add—and what they risk
Prescription stimulants are effective for diagnosed ADHD under medical supervision, according to the National Institute of Mental Health—monitored dosing, follow-up, and screening for cardiovascular and psychiatric risk factors are part of that process. None of that supervision exists when a stimulant is taken without a prescription or borrowed from someone else's. The FDA's own classification of these drugs as Schedule II reflects documented risks of misuse, addiction, overdose, and diversion—not a theoretical concern.
Put next to the evidence gap above, the trade-off is stark: students report using nonprescribed stimulants in the belief it will raise exam performance, but the research connecting that belief to an actual academic benefit is limited, while the dependence, cardiovascular, psychiatric, and legal risks are well documented either way.
What this page can't settle
This page can tell you what trials have actually measured and where the gaps are. It can't tell you whether a specific branded product will work for you—most multi-ingredient formulas haven't been tested as a finished combination, only their individual ingredients have, often at different doses than what's in the bottle. It also can't substitute for a conversation with a doctor if you're considering a prescription stimulant, or if you suspect ADHD is part of why studying feels harder than it should; that's a diagnostic question a supplement, or this article, can't answer.
Your next step
The evidence points to a narrow, honest answer rather than a product pick: caffeine with L-theanine has the best-supported short-term effect on alertness and attention; nonprescribed stimulant use carries real legal and health risk without matching academic-outcome evidence to justify it; and most branded blends are still being evaluated ingredient-by-ingredient rather than as tested combinations. If you want to compare how specific over-the-counter formulas stack up on ingredients, dosing, and price, our comparison of over-the-counter Adderall alternatives covers that ground. If sleep, routine, or workload is the actual driver of exam stress, those are the levers with the most consistent research behind them, independent of any supplement.
By SterlingMedicalCenter.org Editorial Team
Read next